Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avita Medical.
RELATED STOCKHEAD STORIES
News
Closing Bell: Bleak benchmark goes back to the beginning as Wall Street worries widen; RBA holds at 4.1pc
News
Top 10 at 11: Solid drilling results and a massive dope deal have tongues wagging today
Health & Biotech
ScoPo’s Powerplays: Should have stayed in bed as ASX stocks fall but Neuren makes S&P ASX 200
Health & Biotech
ScoPo’s Powerplays: ASX health stock fall but hold onto your hat for reporting season
Health & Biotech
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
Health & Biotech
ASX Health Stocks: Silk Laser gives thumbs up to $180 million Wesfarmers bid, soars 18%
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
Health & Biotech
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
News
Market Highlights: Wall Street retreats, China’s EV domination, and Bitcoin’s 10x call
Health & Biotech
ASX Health Stocks: Sub $50m market cap Austco nabs $7.4m contract, the biggest in its history
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks lower, Sigma wins back Chemist Warehouse deal from EBOS
Health & Biotech
ASX Health Stocks: Avita jumps 14pc on FDA approval; Emyria to start trial on landmark MDMA therapy
Health & Biotech
ScoPo’s Powerplays: ASX health stocks… could be worse
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
News